Research education and courses at the Division of Neurogeriatrics
Approximately 20 PhD students are currently registered at the Division of Neurogeriatrics. In addition, we provide a number of doctoral courses and an advanced course for in dementia diseases for Chinese clinicians and scientists. We are also coordinating the Clinical Research School in Molecular Medicine. Furthermore, our researchers are deeply involved in the Board of Doctoral Education, the Doctoral supervisor training and the Introduction course for doctoral education.
Doctoral courses given at the division:
Advances in cellular, molecular and cognitive neuroscience: From brain to bench and beyond.
The purpose of this course is to introduce diverse aspects of neuroscience as a field to Ph.D. candidates of the doctoral program in neuroscience at NVS. The course will describe major areas of neuroscience such as brain function from the cellular level to the behavioural and cognitive aspects in animal models and in humans. The discussion of the different topics will follow a textbook, but we will develop the contents with state-of-the-art research and frontier theories to give an updated panorama of neuroscience.
The lecturers will develop the topics and provide knowledge to students so they will actively participate in the discussion of given problems, promoting critical thinking and the generation of their own conclusions.
The course will be held in two weeks, from February 28th to March 10th, 2023.
Bibliography: -Turabian (6th ed.). Purves, Dale. Neuroscience. Sunderland, Mass: Sinauer Associates, Publishers, 2010.
Course leaders: Simone Tambaro, Luis Arroyo-García
Neurodegenerative Disorders I - Genes, mechanisms and clinical aspects #5572
The course will cover topics related to the degeneration of neural cells, apoptosis and necrosis as well as the cellular and biochemical reactions to neurodegeneration. During the course we will also present and discuss genetics, epidemiology, pathology, symptoms, diagnosis and treatment strategies of the most common neurodegenerative disorders such as Alzheimer disease, Parkinson disease, frontotemporal dementia, amyotrophic lateral sclerosis and multiple sclerosis. Molecular mechanisms of current and future treatment strategies, disease models and their potential will be presented and discussed. In addition, the students may within group assignments study other neurodegenerative diseases such as dementia with Lewy bodies, ataxias and prion diseases.
Course leaders: Helena Karlström ,Elisabet Åkesson & Caroline Graff
Neurodegenerative disorders II - cellular and molecular mechanisms #2630.
The course is a continuation of course #5572 with a purpose to provide a deeper understanding of neurodegenerative disorders, focusing on molecular mechanisms and techniques used for studying these, as well as treatment strategies.
Course leaders: Sophia Schedin-Weiss, Per Nilsson and Lars Tjernberg
Alzheimer’s disease: Clinical Features and Pathogenic Mechanisms, #5539.
This course provides up-to-date knowledge of different aspects of Alzheimer's disease (AD) from clinical symptoms and diagnosis to molecular mechanisms and future therapeutics.
The course will be given next time in 17 April - 28 April 2023
Course leaders: Per Nilsson, Luana Naia, Nenad Bogdanovic & Una Smailovic
Advanced course in dementia diseases for Chinese clinicians and scientists
Center for Alzheimer Research is organizing an advanced course in dementia diseases for Chinese clinicians and scientists, in collaboration with the China International Exchange and Promotive Association for Medical and Health Care (CPAM). The course involves Karolinska Institutet and the Geriatric clinic at the Karolinska University Hospital, and also other geriatric clinics in Stockholm.
Clinical Research School in Molecular Medicine
The Clinical Research School in Molecular Medicine is a postgraduate program maintained through the joint support from Karolinska Institutet and Region Stockholm. The aim is to provide research-interested clinicians with an adequate postgraduate training, designed to meet the needs of increased and improved translational research. Only clinicians employed by Region Stockholm is eligible for the Research School.